NASDAQ$MEDP
Medpace Holdings Inc. · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
Medpace's Q2 2022 financial performance reflected strong revenue growth and net new business awards.
Medpace Holdings, Inc. announced financial results for the second quarter ended June 30, 2022, featuring a 26.2% increase in revenue to $351.2 million, net new business awards of $450.6 million, and GAAP net income of $49.4 million, or $1.46 per diluted share.
- Revenue increased by 26.2% to $351.2 million compared to the prior-year period.
- Net new business awards increased by 16.3% to $450.6 million, resulting in a net book-to-bill ratio of 1.28x.
- GAAP net income for the second quarter of 2022 was $49.4 million, or $1.46 per diluted share.
- EBITDA increased by 42.0% to $68.1 million, representing an EBITDA margin of 19.4%.
Headline financials
Revenue & EPS history
Medpace · Revenue · Quarterly
$351M
Forward guidance
The Company forecasts 2022 revenue in the range of $1.405 billion to $1.435 billion and GAAP net income for full year 2022 is forecasted in the range of $205.0 million to $215.0 million.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2022
-1.7%
Avg return
Earnings day
-1.6%
Avg return
5 days after
+1.1%
Avg return
30 days after
44%
19 / 43 earnings
Positive
+39.0%
Q3 2022
Best reaction
-31.5%
Q1 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.5% | -19.4% | -14.9% | |
| Q4 2025 | -15.9% | -19.3% | -16.3% | |
| Q3 2025 | +9.0% | +6.2% | +8.2% | |
| Q2 2025 | -0.2% | +1.5% | +7.0% | |
| Q1 2025 | -2.3% | +3.3% | +1.4% | |
| Q4 2024 | -7.5% | -4.0% | -10.3% | |
| Q3 2024 | -8.4% | -7.3% | -8.5% | |
| Q2 2024 | -15.2% | -9.5% | -6.1% | |
| Q1 2024 | +9.4% | +6.4% | +4.8% | |
| Q4 2023 | +11.6% | +20.0% | +25.0% | |
| Q3 2023 | +18.8% | +9.2% | +20.8% | |
| Q2 2023 | +4.6% | +3.9% | +1.8% | |
| Q1 2023 | +10.2% | +5.9% | +7.2% | |
| Q4 2022 | -2.9% | -7.6% | -20.4% | |
| Q3 2022 | +39.0% | +41.5% | +39.2% | |
| Q2 2022 | -2.9% | +5.0% | +3.8% | |
| Q1 2022 | -12.0% | -11.3% | -12.2% | |
| Q4 2021 | -20.6% | -18.2% | -12.1% | |
| Q3 2021 | +13.9% | +21.1% | +14.4% | |
| Q2 2021 | -6.0% | -3.4% | -0.8% | |
| Q1 2021 | -12.8% | -11.3% | -13.3% | |
| Q4 2020 | -2.7% | -5.3% | -2.0% | |
| Q3 2020 | -6.1% | -4.8% | +4.4% | |
| Q2 2020 | +15.5% | +12.8% | +16.7% | |
| Q1 2020 | -2.5% | -11.9% | +9.0% | |
| Q4 2019 | +2.4% | -9.7% | -31.7% | |
| Q3 2019 | +0.8% | -0.5% | +3.8% | |
| Q2 2019 | +24.9% | +19.9% | +27.2% | |
| Q1 2019 | -4.3% | -1.6% | -4.7% | |
| Q4 2018 | -21.3% | -21.8% | -18.4% | |
| Q3 2018 | +0.2% | +13.9% | +21.8% | |
| Q2 2018 | +28.6% | +24.4% | +23.4% | |
| Q1 2018 | +2.3% | -0.0% | +12.9% | |
| Q4 2017 | -15.7% | -14.3% | -5.3% | |
| Q3 2017 | +6.2% | +5.6% | -3.7% | |
| Q2 2017 | +8.0% | +15.1% | +17.2% | |
| Q1 2016 | -31.5% | -29.1% | -12.6% | |
| Q1 2017 | -29.1% | -27.5% | -12.3% | |
| Q4 2014 | -21.3% | -20.7% | -22.2% | |
| Q2 2016 | -21.3% | -20.7% | -22.2% | |
| Q4 2016 | -19.8% | -20.1% | -22.3% | |
| Q3 2016 | +3.8% | +8.1% | +24.0% | |
| Q4 2015 | +3.8% | +8.1% | +24.0% | |
| Q3 2015 | — | — | — | |
| Q2 2015 | — | — | — | |
| Q1 2015 | — | — | — | |
| Q1 2014 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro